Dulce Maria Miranda joined Deloitte in 2015. She is the Intellectual Property Leader for Deloitte Legal at global level, and also leads the IP&IT Law practice of Deloitte Legal in Spain. She previously worked for 22 years at Garrigues where she was partner at its IP and Pharma Departments.
She has worked across different sectors, and has extensive experience in advising clients in the pharmaceutical and life sciences industries, both in IP and regulatory issues. She is a member of Deloitte Spain's Life Sciences and Health Care committee.
Dulce advises on transactions involving the development, exploitation and transfer of intellectual property rights (technology licensing agreements, R&D collaboration agreements, drug development and licensing, manufacturing, distribution, co-promotion and marketing agreements) , and has advised on many high-profile IP disputes, primarily in the fields of patents, trademarks, copyright and trade secrets.
She is also an expert in the legal aspects of the taxation of intangibles.
Among her major projects, Dulce was appointed by the European Commission (DG Research & Innovation) as a member of the group of independent experts to work on a report on intellectual property valuation.
Dulce Miranda has been singled out as a leading lawyer in Intellectual Property and Life Sciences by the most important directories, including Chambers&Partners, The Legal500, Best Lawyers, IAM 250 "Leading Patent & Technology licensing Lawyers", IAM 1000 "The World's leading patent practitioners" and European Legal Experts.
She is an active member of the International Association for the Protection of Intellectual Property (AIPPI) and the European Patent Lawyers Association (EPLAW). She is also a member of the Panel of Arbitrators of the Arbitration and Mediation Center of the Worldwide Intellectual Property Organization (WIPO), and a frequent speaker at various in-house and external seminars.
Dulce Miranda is the co-author of various books and manuals, such as "Comments and Concordances on the Safeguards for and the Rational Use of Medicinal Products and Medical Devices", (Ed.Marcial Pons); "Drafting Agreements in the Biotechnology and Pharmaceutical Industries", (Ed. Oxford University Press); and "Exhaustion of patent rights in ECJ case law", Ed. AIPPI.